Abata Therapeutics
Developer of cell therapy intended to treat autoimmune and inflammatory diseases. The company offers therapies to express t-cell receptors that recognize antigens present in tissue to target the site ...
Valuation
$0
Share Price
N/A
Total Raised
$110.3M
Last Round
N/A